| NCT05681260 | Children´s Cancer Group, China|Shanghai Children´s Medical Center|Beijing Children´s Hospital|Children´s Hospital of Scow University|West China Second University Hospital|Nanjing Children´s Hospital|Qilu Hospital of Shandong University|Tianjin Medical University Cancer Institute and Hospital|Tongji Hospital|Xiangya Hospital of Central South University|The First Affiliated Hospital of Zhengzhou University|Cancer hospital of Shandong Province|Shenzhen Children´s Hospital|Wuhan Children´s Hospital|The Children´s Hospital of Zhejiang University School of Medicine|Shanghai Children´s Hospital|Ruijin Hospital|The Second Hospital of Anhui Medical University|Children´s Hospital of Hebei Province|Cancer Hospital of Henan Province|Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University|Qilu Children´s Hospital | T-cell Lymphoblastic Lymphoma | 2023-02-06 | PHASE3 |
| NCT03553238 | Nanfang Hospital, Southern Medical University | Leukemia, Acute|Leukemia, T Cell|Leukemia, Lymphoblastic | 2016-02-14 | PHASE2|PHASE3 |
| NCT04043494 | University Hospital Muenster|Deutsche Krebshilfe e.V., Bonn (Germany) | Lymphoblastic Lymphoma, Childhood | 2019-08-23 | PHASE3 |
| NCT02845882 | Children´s Cancer Group, China|Shanghai Children´s Medical Center|Tongji Hospital|West China Second University Hospital|Qilu Hospital of Shandong University|Tianjin Medical University Cancer Institute and Hospital|Children´s Hospital of Soochow University|Nanjing Children´s Hospital|Xiangya Hospital of Central South University | Lymphoblastic Lymphoma | 2016-01 | PHASE3 |
| NCT00199069 | Goethe University|Deutsche Krebshilfe e.V., Bonn (Germany) | Adult Acute Lymphocytic Leukemia | 1993-04 | PHASE4 |
| NCT00199056 | Goethe University | Adult Acute Lymphocytic Leukemia | 1999-10 | PHASE4 |
| NCT00136435 | Dana-Farber Cancer Institute|Brigham and Women´s Hospital|Massachusetts General Hospital|Queen Elizabeth II Health Sciences Centre | Acute Lymphoblastic Leukemia | 2002-06 | PHASE2 |
| NCT05660473 | Institute of Hematology & Blood Diseases Hospital, China | Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2022-08-01 | PHASE2 |
| NCT05276284 | Kristoffer Rohrberg | Solid Tumor, Adult|Metastatic Cancer | 2022-09-01 | PHASE1|PHASE2 |
| NCT02518750 | St. Jude Children´s Research Hospital|Novartis Pharmaceuticals|Spectrum Pharmaceuticals, Inc | Acute Lymphoblastic Leukemia|Lymphoma, Non-Hodgkin´s|Leukemia, T-Cell|Leukemia, B-Cell | 2016-11-23 | PHASE2 |
| NCT00521950 | ZonMw: The Netherlands Organisation for Health Research and Development|Radboud University Medical Center | Inflammatory Bowel Diseases|Crohn Disease|Ulcerative Colitis | 2007-09 | NA |
| NCT06533748 | St. Jude Children´s Research Hospital|Pfizer|Amgen | Acute Lymphoblastic Leukemia|Lymphoblastic Lymphoma | 2025-01-23 | PHASE2 |
| NCT06279767 | The First Affiliated Hospital with Nanjing Medical University | Glioblastoma|Cancer|Temozolomide | 2022-07-01 | PHASE1|PHASE2 |
| NCT01432145 | University of Oxford | Breast Cancer|Ovarian Cancer | 2011-05 | PHASE2 |
| NCT03643276 | Martin Schrappe|Deutsche Krebshilfe e.V., Bonn (Germany) | Acute Lymphoblastic Leukemia, Pediatric | 2018-07-15 | PHASE3 |
| NCT03286634 | National Hospital Organization Nagoya Medical Center | Down Syndrome|Acute Lymphoblastic Leukemia|Childhood Cancer | 2017-04-18 | PHASE2 |
| NCT00602134 | Roxane Laboratories | Acute Lymphoblastic Leukemia | 2002-11 | NA |
| NCT00184041 | University of Southern California | Acute Lymphoblastic Leukemia | 2004-07 | PHASE2 |
| NCT01358253 | Ruijin Hospital | Acute Lymphoblastic Leukemia | 2010-12 | PHASE4 |
| NCT00514982 | National Institute of Allergy and Infectious Diseases (NIAID) | Hermanski-Pudlak Syndrome|Colitis|Cytokines|Lymphocytes|Drug Evaluation | 2007-08-07 | PHASE2 |
| NCT02894645 | National University Hospital, Singapore | Acute Lymphoblastic Leukemia (ALL) | 2008-10 | PHASE4 |
| NCT00846703 | Sun Yat-sen University | Acute Lymphoblastic Leukemia | 2008-07 | PHASE4 |
| NCT05506332 | University Hospital, Antwerp | Acute Myeloid Leukemia, in Relapse|Acute Myeloid Leukemia Refractory | 2022-07-15 | PHASE1 |
| NCT06199557 | Haukeland University Hospital | Acute Myeloid Leukemia, Adult|Myelodysplastic Syndromes, Adult | 2024-05-23 | PHASE1|PHASE2 |
| NCT02660762 | Sun Yat-sen University | Leukaemia,Lymphoblastic | 2016-01 | PHASE2 |
| NCT04228393 | Wei Zhao|Institute of Hematology & Blood Diseases Hospital, China|Qianfoshan Hospital|Qilu Hospital of Shandong University|Children´s Hospital of Hebei Province|The Affiliated Hospital of Qingdao University | Acute Lymphoblastic Leukemia, Pediatric | 2020-02-01 | PHASE2|PHASE3 |
| NCT03384654 | Janssen Research & Development, LLC | Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2018-05-14 | PHASE2 |
| NCT02303821 | Amgen|Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) - Study Design & Execution Collaborator|Innovative Therapies For Children with Cancer Consortium | Acute Lymphoblastic Leukemia (ALL) | 2015-02-16 | PHASE1 |
| NCT01324336 | Children´s Mercy Hospital Kansas City|Midwest Cancer Alliance | Acute Lymphoblastic Leukemia | 2011-07 | |
| NCT00176462 | Rutgers, The State University of New Jersey|National Cancer Institute (NCI) | Acute Lymphocytic Leukemia | 2001-02 | PHASE2 |
| NCT02877303 | M.D. Anderson Cancer Center|National Cancer Institute (NCI) | B Acute Lymphoblastic Leukemia|B Lymphoblastic Lymphoma | 2016-11-01 | PHASE2 |
| NCT03020030 | Dana-Farber Cancer Institute|Servier | Acute Lymphoblastic Leukemia, Pediatric | 2017-03-03 | PHASE3 |
| NCT00002744 | Children´s Oncology Group|National Cancer Institute (NCI) | Leukemia | 1996-05 | PHASE3 |
| NCT00002766 | Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI) | Leukemia|Lymphoma | 1996-03 | PHASE3 |
| NCT02101853 | National Cancer Institute (NCI) | Recurrent B Acute Lymphoblastic Leukemia | 2014-12-17 | PHASE3 |
| NCT01256398 | National Cancer Institute (NCI) | Acute Lymphoblastic Leukemia|Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 | 2010-12-14 | PHASE2 |
| NCT02143414 | National Cancer Institute (NCI) | Acute Lymphoblastic Leukemia|B Acute Lymphoblastic Leukemia|B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1|Recurrent Acute Lymphoblastic Leukemia|Refractory Acute Lymphoblastic Leukemia | 2015-06-30 | PHASE2 |
| NCT07431060 | West China Second University Hospital | Langerhans Cell Histiocytosis (LCH) | 2026-02-13 | NA |
| NCT01451515 | St. Jude Children´s Research Hospital|National University of Singapore | Lymphoblastic Lymphoma | 2012-05-25 | PHASE2 |
| NCT00003650 | UNICANCER | Lymphoma | 1997-02 | PHASE3 |
| NCT00003423 | United Kingdom Children´s Cancer Study Group | Lymphoma | 1995-05 | PHASE3 |
| NCT00551460 | SWOG Cancer Research Network|National Cancer Institute (NCI) | Leukemia | 2007-11-15 | PHASE2 |
| NCT00381680 | Children´s Oncology Group|National Cancer Institute (NCI) | B-cell Childhood Acute Lymphoblastic Leukemia|L1 Childhood Acute Lymphoblastic Leukemia|L2 Childhood Acute Lymphoblastic Leukemia|Intermediate Risk Recurrent Childhood Acute Lymphoblastic Leukemia | 2007-03 | PHASE3 |
| NCT00400946 | Dana-Farber Cancer Institute|National Cancer Institute (NCI) | Drug+Agent Toxicity by Tissue+Organ|Leukemia | 2005-04 | PHASE3 |
| NCT00707083 | Prince of Wales Hospital, Shatin, Hong Kong | Leukemia | 2008-05-01 | PHASE3 |
| NCT00005596 | Children´s Oncology Group|National Cancer Institute (NCI) | Leukemia | 2000-04 | PHASE3 |
| NCT01228331 | Universit?tsklinikum Hamburg-Eppendorf | Leukemia | 2010-10 | PHASE2|PHASE3 |
| NCT02910245 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)|ZonMw: The Netherlands Organisation for Health Research and Development | Colitis, Ulcerative | 2016-11 | PHASE3 |
| NCT00501826 | M.D. Anderson Cancer Center|National Cancer Institute (NCI) | T Acute Lymphoblastic Leukemia|T Lymphoblastic Lymphoma | 2007-07-11 | PHASE2 |
| NCT00002785 | Children´s Oncology Group|National Cancer Institute (NCI) | Leukemia | 1996-07 | PHASE2 |
| NCT01230983 | Children´s Oncology Group|National Cancer Institute (NCI) | Cardiac Toxicity|Leukemia|Lymphoma | 1996-06 | PHASE3 |
| NCT01700946 | St. Jude Children´s Research Hospital|Cookies for Kids´ Cancer|Assisi Foundation | Recurrent B-Cell Childhood Acute Lymphoblastic Leukemia|Recurrent Childhood B-Lymphoblastic Lymphoma | 2013-04-15 | PHASE2 |
| NCT01005758 | Ohio State University Comprehensive Cancer Center|National Cancer Institute (NCI) | Leukemia | 2009-01 | PHASE2 |
| NCT00002812 | Children´s Oncology Group|National Cancer Institute (NCI) | Leukemia | 1996-09 | PHASE3 |
| NCT05959720 | Instituto do Cancer do Estado de S?o Paulo|Servier | Acute Lymphoid Leukemia|Minimal Residual Disease|Gene Abnormality|Chemotherapeutic Toxicity | 2023-09-05 | |
| NCT00022737 | National Cancer Institute (NCI) | Childhood Acute Lymphoblastic Leukemia in Remission|Recurrent Childhood Acute Lymphoblastic Leukemia | 2002-10 | PHASE3 |
| NCT00003437 | Medical Research Council | Leukemia | 1997-01 | PHASE3 |
| NCT00016302 | National Cancer Institute (NCI) | T-cell Childhood Acute Lymphoblastic Leukemia|Untreated Childhood Acute Lymphoblastic Leukemia | 2001-04 | NA |
| NCT00005603 | Children´s Oncology Group|National Cancer Institute (NCI) | Leukemia | 2000-03 | PHASE3 |
| NCT02419469 | M.D. Anderson Cancer Center|Jazz Pharmaceuticals | Leukemia|Precursor-B Acute Lymphoblastic Leukemia|Lymphoblastic Lymphoma|Lymphoma | 2015-11-13 | PHASE2 |
| NCT00198991 | Goethe University|Deutsche Krebshilfe e.V., Bonn (Germany)|German Federal Ministry of Education and Research | Adult Acute Lymphocytic Leukemia | 2003-04 | PHASE4 |
| NCT03914625 | National Cancer Institute (NCI) | B Acute Lymphoblastic Leukemia|B Lymphoblastic Lymphoma|Down Syndrome | 2019-07-03 | PHASE3 |
| NCT02553460 | St. Jude Children´s Research Hospital|Gateway for Cancer Research|Baylor College of Medicine | Acute Lymphoblastic Leukemia | 2016-01-29 | PHASE1|PHASE2 |
| NCT00015873 | Dutch Childhood Oncology Group | Leukemia | 1999-05 | PHASE3 |
| NCT00187005 | St. Jude Children´s Research Hospital | Acute Lymphoblastic Leukemia | 1998-07 | PHASE3 |
| NCT00199017 | Johann Wolfgang Goethe University Hospital | Lymphoma, Lymphoblastic | 2004-04 | PHASE4 |
| NCT07072585 | Children´s Oncology Group | Stage II T Lymphoblastic Leukemia+Lymphoma|Stage III T Lymphoblastic Leukemia+Lymphoma|Stage IV T Lymphoblastic Leukemia+Lymphoma|T Acute Lymphoblastic Leukemia|T Lymphoblastic Lymphoma | 2026-06-28 | PHASE2|PHASE3 |
| NCT00275106 | Children´s Cancer and Leukaemia Group|European Inter-group Cooperation on Childhood and Adolescent Non Hodgkin Lymphoma | Lymphoma | 2004-09 | PHASE3 |
| NCT02177071 | Groupe d´Etude Therapeutique des Affections Inflammatoires Digestives|Saint-Louis Hospital, Paris, France | Crohn´s Disease | 2015-10-09 | PHASE4 |
| NCT00720109 | National Cancer Institute (NCI) | Acute Lymphoblastic Leukemia|Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1|Childhood B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 | 2008-07-14 | PHASE2|PHASE3 |
| NCT00526305 | PETHEMA Foundation | Acute Lymphoblastic Leukemia | 2000-01 | PHASE4 |
| NCT00018954 | National Institutes of Health Clinical Center (CC)|National Cancer Institute (NCI) | Leukemia|Lymphoma | 1992-10 | PHASE2 |
| NCT00002665 | SWOG Cancer Research Network|National Cancer Institute (NCI) | Leukemia|Neutropenia|Thrombocytopenia | 1995-07 | PHASE2 |
| NCT02852694 | PIBD-Net|European Commission | Crohn´s Disease | 2017-02-28 | PHASE4 |
| NCT03518112 | M.D. Anderson Cancer Center|National Cancer Institute (NCI) | Philadelphia Chromosome Negative|Recurrent B Acute Lymphoblastic Leukemia|Refractory B Acute Lymphoblastic Leukemia | 2018-04-18 | PHASE2 |
| NCT00199004 | Johann Wolfgang Goethe University Hospital | Adult Acute Lymphocytic Leukemia | 2004-04 | PHASE4 |
| NCT00002618 | Children´s Oncology Group|National Cancer Institute (NCI) | Lymphoma | 1994-12 | PHASE3 |
| NCT02420717 | M.D. Anderson Cancer Center|National Cancer Institute (NCI) | Recurrent B Acute Lymphoblastic Leukemia|Recurrent Ph-Like Acute Lymphoblastic Leukemia|Refractory B Acute Lymphoblastic Leukemia|Refractory Ph-Like Acute Lymphoblastic Leukemia | 2015-07-15 | PHASE2 |
| NCT00198978 | Goethe University | Adult Acute Lymphocytic Leukemia | 2003-01 | PHASE4 |
| NCT00268528 | Children´s Oncology Group|National Cancer Institute (NCI) | Childhood Acute Lymphoblastic Leukemia in Remission | 2005-05-30 | |
| NCT00199095 | Goethe University | Adult Acute Lymphocytic Leukemia | 1997-02 | PHASE4 |
| NCT03488225 | M.D. Anderson Cancer Center|National Cancer Institute (NCI) | Acute Lymphoblastic Leukemia in Remission|B Acute Lymphoblastic Leukemia|B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative | 2018-03-28 | PHASE2 |
| NCT02036489 | PETHEMA Foundation | Acute Lymphobkastic Leukemia | 2008-01 | PHASE4 |
| NCT00131027 | Japan Adult Leukemia Study Group | Lymphoblastic Leukemia, Acute | 2002-09 | PHASE3 |
| NCT00866918 | Children´s Oncology Group|National Cancer Institute (NCI) | Childhood Acute Promyelocytic Leukemia With PML-RARA|Myeloid Neoplasm | 2009-03-09 | PHASE3 |
| NCT00430118 | University Hospital Schleswig-Holstein | Leukemia | 2000-07 | PHASE3 |
| NCT02228772 | Massachusetts General Hospital|Millennium Pharmaceuticals, Inc. | Acute Lymphoblastic Leukemia|Lymphoblastic Lymphoma|B-cell Adult Acute Lymphoblastic Leukemia|T-cell Adult Acute Lymphoblastic Leukemia | 2014-12 | PHASE1 |
| NCT03117751 | St. Jude Children´s Research Hospital|Incyte Corporation|Amgen|Servier | Acute Lymphoblastic Leukemia|Acute Lymphoblastic Lymphoma | 2017-03-29 | PHASE2|PHASE3 |
| NCT00019409 | National Institutes of Health Clinical Center (CC)|National Cancer Institute (NCI) | Leukemia | 1999-10 | PHASE3 |
| NCT04440267 | Institute of Hematology & Blood Diseases Hospital, China | Acute Leukemia of Ambiguous Lineage | 2020-07-08 | PHASE2 |
| NCT02205762 | North American Consortium for Histiocytosis|Histiocyte Society | Langerhans Cell Histiocytosis | 2016-11-02 | PHASE2|PHASE3 |
| NCT00004688 | Emory University | Anaplastic Astrocytoma|Anaplastic Oligodendroglioma|Mixed Gliomas|Glioblastoma Multiforme|Recurrent Brain Tumor | 1996-08 | PHASE2 |
| NCT01085617 | University College, London | Leukemia|Mucositis|Oral Complications | 2010-12 | |
| NCT00186875 | St. Jude Children´s Research Hospital | Acute Lymphoblastic Leukemia|Lymphoma, Lymphoblastic | 2003-11 | PHASE2 |
| NCT00648336 | Mylan Pharmaceuticals Inc | Healthy | 2003-11 | PHASE1 |
| NCT02881086 | Goethe University | Acute Lymphoblastic Leukemia|Lymphoblastic Lymphoma | 2016-08 | PHASE3 |
| NCT00002531 | Johann Wolfgang Goethe University Hospital | Leukemia | 1993-01 | PHASE2 |
| NCT02413047 | Indiana University | Inflammatory Bowel Disease|Ulcerative Colitis|Crohn´s Disease | 2015-05 | NA |
| NCT02419755 | St. Jude Children´s Research Hospital | Mixed Lineage Acute Leukemia|Acute Myeloid Leukemia|Acute Lymphoid Leukemia | 2015-04-14 | PHASE2 |
| NCT02828358 | National Cancer Institute (NCI) | Acute Leukemia of Ambiguous Lineage|B Acute Lymphoblastic Leukemia|Mixed Phenotype Acute Leukemia | 2017-04-01 | PHASE2 |
| NCT00973752 | Massachusetts General Hospital|Dana-Farber Cancer Institute|Beth Israel Deaconess Medical Center|Enzon Pharmaceuticals, Inc.|Genzyme, a Sanofi Company | Acute Lymphoblastic Leukemia | 2009-08 | PHASE2 |
| NCT05303792 | Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) | B Acute Lymphoblastic Leukemia|B Lymphoblastic Lymphoma | 2023-06-09 | PHASE2 |
| NCT00061945 | National Cancer Institute (NCI) | Acute Undifferentiated Leukemia|B-cell Adult Acute Lymphoblastic Leukemia|B-cell Childhood Acute Lymphoblastic Leukemia|L1 Adult Acute Lymphoblastic Leukemia|L1 Childhood Acute Lymphoblastic Leukemia|L2 Adult Acute Lymphoblastic Leukemia|L2 Childhood Acute Lymphoblastic Leukemia|Philadelphia Chromosome Negative Adult Precursor Acute Lymphoblastic Leukemia|Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia|Philadelphia Chromosome Positive Childhood Precursor Acute Lymphoblastic Leukemia|T-cell Adult Acute Lymphoblastic Leukemia|T-cell Childhood Acute Lymphoblastic Leukemia|Untreated Adult Acute Lymphoblastic Leukemia|Untreated Childhood Acute Lymphoblastic Leukemia | 2003-06 | PHASE1|PHASE2 |
| NCT00136084 | St. Jude Children´s Research Hospital|National Cancer Institute (NCI) | Leukemia, Myelocytic, Acute | 2002-08 | PHASE3 |
| NCT00494897 | PETHEMA Foundation | Acute Lymphoblastic Leukemia | 1996-06 | PHASE4 |
| NCT00187122 | St. Jude Children´s Research Hospital | Lymphoblastic Lymphoma | 1993-03 | NA |
| NCT01117441 | University Hospital Schleswig-Holstein|Deutsche Krebshilfe e.V., Bonn (Germany) | Leukemia | 2010-06 | PHASE3 |
| NCT00004228 | Children´s Oncology Group|National Cancer Institute (NCI) | Lymphoma | 2000-06 | PHASE3 |
| NCT04216524 | M.D. Anderson Cancer Center|National Cancer Institute (NCI) | Blastic Plasmacytoid Dendritic Cell Neoplasm | 2020-05-29 | PHASE2 |
| NCT02523976 | Institute of Hematology & Blood Diseases Hospital, China | Acute,Leukemia, Lymphoid | 2015-08-01 | PHASE2 |
| NCT01697020 | Nova Laboratories Limited | Acute Lymphoblastic Leukemia | 2012-09 | PHASE1 |
| NCT00853008 | PETHEMA Foundation | Acute Lymphoblastic Leukemia | 2003-01 | PHASE4 |
| NCT00059839 | Children´s Oncology Group|National Cancer Institute (NCI) | Lymphoma | 2003-11 | PHASE3 |
| NCT03571321 | University of Chicago|Incyte Corporation | Acute Lymphoblastic Leukemia|ALL, Childhood|ALL | 2019-05-28 | PHASE1 |
| NCT07227584 | Dana-Farber Cancer Institute | Acute Lymphoblastic Leukemia|Philadelphia Chromosome-Negative Lymphoblastic Leukemia|Acute Lymphoblastic Leukemia (ALL)|Leukemia | 2026-04 | PHASE2 |
| NCT00343369 | Universit?tsklinikum Hamburg-Eppendorf | Leukemia | 2003-01 | NA |
| NCT01156883 | Gruppo Italiano Malattie EMatologiche dell´Adulto | Leukemia | 2010-04 | NA |
| NCT00262925 | National Cancer Institute (NCI) | Recurrent Adult Acute Lymphoblastic Leukemia | 2006-06 | PHASE2 |
| NCT01190930 | Children´s Oncology Group|National Cancer Institute (NCI) | Acute Lymphoblastic Leukemia|Adult B Lymphoblastic Lymphoma|Ann Arbor Stage I B Lymphoblastic Lymphoma|Ann Arbor Stage II B Lymphoblastic Lymphoma|Childhood B Acute Lymphoblastic Leukemia|Childhood B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1|Childhood B Lymphoblastic Lymphoma|Down Syndrome|Hypodiploid B Acute Lymphoblastic Leukemia|Philadelphia Chromosome Positive | 2010-08-09 | PHASE3 |
| NCT06175702 | PETHEMA Foundation | Lymphoblastic Leukemia|Philadelphia-Positive ALL|Adult ALL | 2023-12-25 | |
| NCT02003222 | National Cancer Institute (NCI)|Canadian Cancer Trials Group | Acute Lymphoblastic Leukemia|B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative | 2014-05-19 | PHASE3 |
| NCT00187083 | St. Jude Children´s Research Hospital | Acute Lymphoblastic Leukemia | 1997-02 | PHASE3 |
| NCT00002514 | Eastern Cooperative Oncology Group|National Cancer Institute (NCI)|Medical Research Council | Leukemia | 1993-05-07 | PHASE3 |
| NCT02688140 | Technische Universit?t Dresden|Gruppo Italiano Malattie EMatologiche dell´Adulto|Groupe Francophone des Myelodysplasies|HOVON - Dutch Haemato-Oncology Association|Programa para el Tratamiento de Hemopatías Malignas|German Federal Ministry of Education and Research|Teva Pharmaceuticals Europe | Acute Promyelocytic Leukemia | 2016-06 | PHASE3 |
| NCT03007147 | Children´s Oncology Group|EsPhALL|National Cancer Institute (NCI) | Acute Lymphoblastic Leukemia|B Acute Lymphoblastic Leukemia|Mixed Phenotype Acute Leukemia|T Acute Lymphoblastic Leukemia | 2017-08-08 | PHASE3 |
| NCT00005585 | Children´s Oncology Group|National Cancer Institute (NCI) | Leukemia | 2000-04 | PHASE3 |
| NCT00089349 | National Cancer Institute (NCI) | Recurrent Childhood Acute Lymphoblastic Leukemia | 2004-07 | PHASE2 |
| NCT00005945 | Children´s Oncology Group|National Cancer Institute (NCI) | Leukemia | 2000-06 | PHASE3 |
| NCT05157971 | City of Hope Medical Center|National Cancer Institute (NCI) | B Acute Lymphoblastic Leukemia|Ph-Like Acute Lymphoblastic Leukemia | 2022-03-17 | PHASE1 |
| NCT00187057 | St. Jude Children´s Research Hospital|Children´s Hospital of Philadelphia|National Cancer Institute (NCI) | Ataxia-Telangiectasia | 2002-09 | NA |
| NCT00774982 | Teva GTC | Crohns Disease | 2008-12 | PHASE1 |
| NCT01094613 | Teva GTC | Crohn´s Disease | 2010-11 | PHASE1|PHASE2 |
| NCT00549848 | St. Jude Children´s Research Hospital|National Cancer Institute (NCI)|Enzon Pharmaceuticals, Inc.|National Institute of General Medical Sciences (NIGMS) | Acute Lymphoblastic Leukemia | 2007-10-29 | PHASE3 |
| NCT00408005 | National Cancer Institute (NCI) | T Acute Lymphoblastic Leukemia|T Lymphoblastic Lymphoma | 2007-01-30 | PHASE3 |
| NCT00109837 | SWOG Cancer Research Network|National Cancer Institute (NCI) | Leukemia | 2005-04 | PHASE2 |
| NCT02776605 | PETHEMA Foundation | ALL | 2016-06 | PHASE2 |
| NCT00492856 | SWOG Cancer Research Network|National Cancer Institute (NCI) | Leukemia | 2007-06-01 | PHASE3 |
| NCT06317662 | National Cancer Institute (NCI) | Acute Leukemia of Ambiguous Lineage|B Acute Lymphoblastic Leukemia | 2025-06-05 | PHASE2 |
| NCT00003783 | Children´s Oncology Group|National Cancer Institute (NCI) | Leukemia | 1999-03 | PHASE2 |
| NCT00276601 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|National Cancer Institute (NCI) | Leukemia | 2004-10 | PHASE2 |
| NCT00003671 | Children´s Oncology Group|National Cancer Institute (NCI) | Leukemia | 1998-12 | PHASE2 |
| NCT05192889 | St. Jude Children´s Research Hospital|AbbVie | Refractory Acute Lymphoblastic Leukemia|Relapsed Acute Lymphoblastic Leukemia | 2022-08-25 | PHASE1|PHASE2 |
| NCT06210750 | National Cancer Institute (NCI) | T Acute Lymphoblastic Leukemia|T Lymphoblastic Lymphoma | 2024-08-09 | PHASE2 |
| NCT00866307 | Children´s Oncology Group|National Cancer Institute (NCI) | Acute Lymphoblastic Leukemia|Adult B Acute Lymphoblastic Leukemia|Childhood B Acute Lymphoblastic Leukemia | 2009-02-23 | PHASE1 |
| NCT02883049 | National Cancer Institute (NCI) | B Acute Lymphoblastic Leukemia|B Acute Lymphoblastic Leukemia, BCR-ABL1-Like|Central Nervous System Leukemia|Testicular Leukemia | 2012-02-29 | PHASE3 |
| NCT00002704 | National Cancer Institute (NCI) | Leukemia | 1996-01 | PHASE2 |
| NCT00075725 | Children´s Oncology Group|National Cancer Institute (NCI) | Acute Lymphoblastic Leukemia|Adult B Acute Lymphoblastic Leukemia|Childhood B Acute Lymphoblastic Leukemia | 2003-12-29 | PHASE3 |
| NCT03370601 | University Hospital, Lille | Inflammatory Bowel Diseases | 2017-01-03 | NA |
| NCT00482833 | Gruppo Italiano Malattie EMatologiche dell´Adulto|Study Alliance Leukemia (SAL) Group | Leukemia | 2007-08 | PHASE3 |
| NCT00458848 | Gruppo Italiano Malattie EMatologiche dell´Adulto | Leukemia | 2004-10 | PHASE2 |
| NCT00047268 | European Working Group of MDS in Childhood | Leukemia|Myelodysplastic+Myeloproliferative Neoplasms | 1998-07 | PHASE3 |
| NCT00022126 | Children´s Oncology Group|National Cancer Institute (NCI) | Leukemia | 2002-11 | PHASE2 |
| NCT06639958 | Children´s Oncology Group | Acute Lymphoblastic Leukemia|Childhood Acute Lymphoblastic Leukemia | 2024-12-04 | NA |
| NCT00096135 | Children´s Oncology Group|National Cancer Institute (NCI) | Leukemia | 2004-11 | NA |
| NCT05032183 | M.D. Anderson Cancer Center | Recurrent Adult Lymphoblastic Lymphoma|Recurrent B Acute Lymphoblastic Leukemia|Recurrent T Acute Lymphoblastic Leukemia|Refractory B Acute Lymphoblastic Leukemia|Refractory Lymphoblastic Lymphoma|Refractory T Acute Lymphoblastic Leukemia | 2022-02-17 | PHASE1|PHASE2 |
| NCT00002756 | Children´s Oncology Group|National Cancer Institute (NCI) | Leukemia | 1996-06 | PHASE2 |
| NCT06099366 | Hee Young Ju|Asan Medical Center|Seoul National University Hospital|Seoul St. Mary´s Hospital|Severance Hospital|Pusan National University Yangsan Hospital|Korea University Anam Hospital|Chonnam National University Hospital|Jeju National University Hospital | Lymphoblastic Leukemia in Children | 2024-03-05 | PHASE2 |
| NCT00103285 | Children´s Oncology Group|National Cancer Institute (NCI) | Acute Lymphoblastic Leukemia|Childhood B Acute Lymphoblastic Leukemia | 2005-04-11 | PHASE3 |
| NCT00866749 | M.D. Anderson Cancer Center | Lymphoblastic Leukemia|Lymphoblastic Lymphoma | 2006-09-12 | PHASE2 |
| NCT02611492 | Assistance Publique - H?pitaux de Paris | Philadelphia Chromosome Positive Adult Acute Lymphoblastic Leukemia | 2016-04 | PHASE3 |
| NCT00671034 | Children´s Oncology Group|National Cancer Institute (NCI) | Acute Lymphoblastic Leukemia|Adult B Acute Lymphoblastic Leukemia|Childhood B Acute Lymphoblastic Leukemia | 2008-07-21 | PHASE3 |
| NCT05848687 | Tanja Andrea Gruber|The Pediatric Oncology Experimental Therapeutics Investigators´ Consortium|Amgen|Lucile Packard Foundation for Children´s Health|Kura Oncology, Inc.|United States Department of Defense|Cannonball Kid´s Cancer | Lymphoblastic Leukemia | 2023-11-03 | PHASE1|PHASE2 |
| NCT00003728 | European Organisation for Research and Treatment of Cancer - EORTC | Leukemia|Lymphoma | 1998-12 | PHASE3 |
| NCT00002701 | European Organisation for Research and Treatment of Cancer - EORTC|Gruppo Italiano Malattie EMatologiche dell´Adulto | Leukemia | 1995-10 | PHASE3 |
| NCT00526175 | PETHEMA Foundation | Acute Lymphoblastic Leukemia | 2001-06 | PHASE4 |
| NCT01503632 | Children´s Oncology Group|National Cancer Institute (NCI) | Acute Lymphoblastic Leukemia | 2012-02-21 | PHASE3 |
| NCT02723994 | Incyte Corporation|Children´s Oncology Group | Leukemia | 2016-09-30 | PHASE2 |
| NCT00557193 | Children´s Oncology Group|National Cancer Institute (NCI) | Acute Lymphoblastic Leukemia|Acute Undifferentiated Leukemia|Childhood T Acute Lymphoblastic Leukemia | 2008-01-15 | PHASE3 |
| NCT00131053 | Japan Adult Leukemia Study Group | Lymphoblastic Leukemia, Acute | 2002-09 | PHASE2 |
| NCT06390319 | St. Jude Children´s Research Hospital|AbbVie | T-cell Acute Lymphoblastic Leukemia|T-cell Lymphoma|Mixed Phenotype Acute Leukemia | 2024-12-27 | PHASE2 |
| NCT00003700 | Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) | Leukemia | 1999-01 | PHASE2 |
| NCT06336395 | National University Hospital, Singapore | B Lymphoblastic Leukemia | 2020-03-04 | PHASE2 |
| NCT00558519 | Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) | Leukemia | 2008-03-12 | PHASE2 |
| NCT00003934 | National Cancer Institute (NCI) | Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)|Adult Acute Promyelocytic Leukemia (M3)|Childhood Acute Promyelocytic Leukemia (M3)|Untreated Adult Acute Myeloid Leukemia|Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies | 1999-06 | PHASE3 |
| NCT00002700 | European Organisation for Research and Treatment of Cancer - EORTC|Acute Leukemia French Association | Leukemia|Lymphoma | 1995-08 | PHASE3 |
| NCT04546399 | National Cancer Institute (NCI) | Down Syndrome|Recurrent B Acute Lymphoblastic Leukemia | 2020-12-17 | PHASE2 |
| NCT03920813 | Shandong University | Acute Lymphoblastic Leukemia | 2015-01 | PHASE4 |
| NCT05645718 | M.D. Anderson Cancer Center | Leukemia | 2023-07-14 | PHASE2 |
| NCT03959085 | Children´s Oncology Group|National Cancer Institute (NCI) | B Acute Lymphoblastic Leukemia|B Lymphoblastic Lymphoma|Central Nervous System Leukemia|Mixed Phenotype Acute Leukemia|Testicular Leukemia | 2019-10-31 | PHASE3 |
| NCT01371630 | M.D. Anderson Cancer Center|National Cancer Institute (NCI) | B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1|B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative|Burkitt-Like Lymphoma With 11q Aberration|High Grade B-Cell Lymphoma With MYC and BCL2 and+or BCL6 Rearrangements|High Grade B-Cell Lymphoma, Not Otherwise Specified|Recurrent B Acute Lymphoblastic Leukemia|Recurrent Burkitt Lymphoma|Refractory B Acute Lymphoblastic Leukemia|Refractory Burkitt Lymphoma | 2011-08-26 | PHASE1|PHASE2 |
| NCT00550992 | Dutch Childhood Oncology Group|BFM Germany|CORS Monza Italy|Associazione Italiana Ematologia Oncologia Pediatrica|Australian and New Zealand Children´s Oncology Group|BFM Austria|CLCG France Belgium Portugal|COALL Germany|CPH, Czech republic|DFCI consortium USA|FRALLE France|Hong Kong Government|MD Anderson USA|NOPHO Scandinavian countries|PINDA, Chile|PPLLSG Poland|Seattle USA|SJCRH USA|UKCCSG United Kingdom | Leukemia | 2006-01 | NA |
| NCT01629628 | Tel-Aviv Sourasky Medical Center|Abbott | Crohn Disease | 2012-07 | PHASE3 |
| NCT06918431 | City of Hope Medical Center|National Cancer Institute (NCI) | B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative|Lymphoblastic Lymphoma | 2025-10-10 | PHASE2 |
| NCT02112916 | National Cancer Institute (NCI) | Adult T Acute Lymphoblastic Leukemia|Ann Arbor Stage II Adult Lymphoblastic Lymphoma|Ann Arbor Stage II Childhood Lymphoblastic Lymphoma|Ann Arbor Stage III Adult Lymphoblastic Lymphoma|Ann Arbor Stage III Childhood Lymphoblastic Lymphoma|Ann Arbor Stage IV Adult Lymphoblastic Lymphoma|Ann Arbor Stage IV Childhood Lymphoblastic Lymphoma|Childhood T Acute Lymphoblastic Leukemia | 2014-10-04 | PHASE3 |
| NCT03150693 | Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) | B Acute Lymphoblastic Leukemia | 2017-09-20 | PHASE3 |
| NCT00764907 | University Hospital, Motol | Leukemia | 2002-11 | PHASE3 |
| NCT00613457 | Associazione Italiana Ematologia Oncologia Pediatrica | Leukemia | 2000-09 | PHASE3 |
| NCT06124157 | National Cancer Institute (NCI) | B Acute Lymphoblastic Leukemia | 2025-05-30 | PHASE2 |
| NCT00137111 | St. Jude Children´s Research Hospital|National Cancer Institute (NCI) | Lymphoblastic Leukemia, Acute | 2000-07-08 | PHASE3 |
| NCT02200978 | South China Children´s Leukemia Group | Childhood Acute Promyelocytic Leukemia | 2011-09 | PHASE4 |
| NCT07462299 | The Children´s Hospital of Zhejiang University School of Medicine|Zhejiang University | Childhood Acute Lymphoblastic Leukemia | 2026-02-20 | NA |
| NCT00962767 | Wyeth is now a wholly owned subsidiary of Pfizer | Leukemia, Myelocytic, Acute | 2002-05 | PHASE3 |
| NCT00287170 | Teva GTC | Crohn´s Disease | 2006-07 | PHASE1|PHASE2 |
| NCT00476190 | Dana-Farber Cancer Institute|Massachusetts General Hospital|Boston Children´s Hospital|NCIC Clinical Trials Group | Acute Lymphoblastic Leukemia | 2007-04 | PHASE2 |